Harvard Bioscience, Inc.

HBIO·NasdaqCM·Healthcare
Compare
8.61−0.06 (−0.69%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close8.67
Open8.85
Day range8.578.85
52-week range4.009.10
Off day high−2.71%
Off 52-week high−5.38%
Volume9.92K
Avg. volume (3M)19.49K
Market cap39.20M
EPS (TTM)-2.31
Forward P/E13.35
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.47
Shares outstanding4.55M
Short interest1.12% of float
Earnings dateNov 10, 2026
Analyst target10.25
Profit margin−11.86%

Against its peers

Compare in full ›
HBIO BLFS SRT.F ALIF-B.ST RGEN DIM.PA
Market cap 39.20M — 15.64B 22.86B 11.39B 22.26B
P/E (TTM) — — 71.7 35.6 — 68.7
Forward P/E 13.3 — 34.5 59.0 67.1 37.8
Price/book 5.3 — 5.8 3.8 4.8 5.1
Dividend yield — — 0.32% 0.81% — 0.31%
1-year change +56.55% — +28.38% −0.70% +22.91% +17.44%
Today −0.69% 0.00% −0.66% +1.68% −0.04% +2.33%

The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.

Latest news

All HBIO news ›

From the 4Search news index, newest first.

In the news

3mentions in 30 days
3with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance